Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Breddin

Showing results (121-130 of 213) with videos related to

Pageof 22
Sort By:
VASA. Supplementum|January 1, 1991
[Objective assessment of the risk of edema in patients with venous diseases and healthy vein probands using optoelectronic volumetry]O K Bellinger, C M Kirchmaier, H K Breddin
Polish Journal of Pharmacology|May 1, 1996
Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosisK Krupiński, J Giedrojć, H K Breddin, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Increased platelet aggregation in diabetic patients and its significance as risk factor for vascular diseases]W Jäger, U Pietsch, H J Krzywanek, et al.
Klinische Wochenschrift|March 15, 1983
[Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy]R Simrock, H Spahn, H K Breddin, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1991
Report on a discussion forum: "Medical and surgical application of recombinant hirudin"J M Walenga, F Markwardt, K Breddin, et al.
VASA. Supplementum|January 1, 1991
[Inhibition of induced thrombocyte aggregation in the presence of endothelial cells by dipyridamole]C M Kirchmaier, J Altorjay, O Bellinger, et al.
Haemostasis|January 1, 1980
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumonK Breddin, D Loew, K Lechner, et al.
Deutsche Medizinische Wochenschrift (1946)|November 27, 1987
[Jellyfish poisoning]V Hach-Wunderle, D Mebs, K Frederking, et al.
Artery|January 1, 1980
A platelet stimulating fraction in human and animal tissuesC M Kirchmaier, N Bender, A A Sayegh, et al.
Thrombosis Research|July 18, 2001
Antiplatelet and anticoagulant effects of "HN-11 500," a selective thromboxane receptor antagonistJ F Schenk, P Radziwon, H Fellier, et al.
Pageof 22

Showing results (121-130 of 213) with videos related to

Sort By:
Pageof 22
VASA. Supplementum|January 1, 1991
[Objective assessment of the risk of edema in patients with venous diseases and healthy vein probands using optoelectronic volumetry]O K Bellinger, C M Kirchmaier, H K Breddin
Polish Journal of Pharmacology|May 1, 1996
Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosisK Krupiński, J Giedrojć, H K Breddin, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Increased platelet aggregation in diabetic patients and its significance as risk factor for vascular diseases]W Jäger, U Pietsch, H J Krzywanek, et al.
Klinische Wochenschrift|March 15, 1983
[Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy]R Simrock, H Spahn, H K Breddin, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1991
Report on a discussion forum: "Medical and surgical application of recombinant hirudin"J M Walenga, F Markwardt, K Breddin, et al.
VASA. Supplementum|January 1, 1991
[Inhibition of induced thrombocyte aggregation in the presence of endothelial cells by dipyridamole]C M Kirchmaier, J Altorjay, O Bellinger, et al.
Haemostasis|January 1, 1980
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumonK Breddin, D Loew, K Lechner, et al.
Deutsche Medizinische Wochenschrift (1946)|November 27, 1987
[Jellyfish poisoning]V Hach-Wunderle, D Mebs, K Frederking, et al.
Artery|January 1, 1980
A platelet stimulating fraction in human and animal tissuesC M Kirchmaier, N Bender, A A Sayegh, et al.
Thrombosis Research|July 18, 2001
Antiplatelet and anticoagulant effects of "HN-11 500," a selective thromboxane receptor antagonistJ F Schenk, P Radziwon, H Fellier, et al.
Pageof 22